http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a18a20c21fb045edc9fc8e37f87c59d9
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Colombatti |
| name | Alfonso Colombatti |
| given-name | Alfonso |
| organization-name | Experimental Oncology 2, CRO, IRCCS, National Cancer Institute, Aviano (PN), Italy; Department of Medical and Biomedical Sciences, University of Udine, Udine, Italy; MATI (Microgravity, Ageing, Training, Immobility) Excellence Center, University of Udine, Udine, Italy 3 CRO, Aviano,; Università di Udine 4 Dipartimento di Scienze e Biotecnologie Biomediche , Division of Experimental Oncology 2, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico, National Cancer Institute, 33081 Aviano, Italy 1; Department of Biomedical Science and Technology 2 and 3; Microgravity, Ageing, Training, and Immobility Excellence Center, University of Udine, 33100 Udine, Italy 2 and 3; Department of Biomedical Science and Technology 2 and 3; Microgravity, Ageing, Training, and Immobility Excellence Center, University of Udine, 33100 Udine, Italy 2 and 3 Centro di Riferimento Oncologico Aviano, Italy; University of Udine, Udine Authors' Affiliations: 1Experimental Oncology 2, CRO, IRCCS, National Cancer Institute, Aviano (PN), Italy; 2Department of Biomedical Science and Technology, and 3MATI (Microgravity, Ageing, Training, Immobility) Excellence Center, University of Udine, Udine, Italy; Authors' Affiliations: 1Experimental Oncology 2, CRO, IRCCS, National Cancer Institute, Aviano (PN), Italy; 2Department of Biomedical Science and Technology, and 3MATI (Microgravity, Ageing, Training, Immobility) Excellence Center, University of Udine, Udine, Italy; Authors' Affiliations: 1Experimental Oncology 2, CRO, IRCCS, National Cancer Institute, Aviano (PN), Italy; 2Department of Biomedical Science and Technology, and 3MATI (Microgravity, Ageing, Training, Immobility) Excellence Center, University of Udine, Udine, Italy Department of Translational Research CRO‐IRCCS National Cancer Institute Aviano 33081 Italy Division of Experimental Oncology 2, Department of Molecular Oncology and Translational Research, CRO-IRCCS, Aviano, Pordenone, Italy; Department of Biomedical Sciences and Technologies, University of Udine, Udine, Italy; MATI Center of Excellence, University of Udine, Udine, Italy Department of Experimental Oncology 2, CRO Aviano National Cancer Institute, Aviano, PN, Italy Division of Experimental Oncology 2, Centro di Riferimento Oncologico, Istituto Nazionale Tumori, IRCCS Aviano 33081, Italy; Dipartimento di Scienze e Tecnologie Biomediche, and MATI Center of Excellence, University of Udine, 33100 Udine, Italy From the Divisione di Oncologia Sperimentale 2 and Divisione di Oncologia Sperimentale 1, CRO, Aviano, Italy; the Department of Pathology, City Hospital, Belluno, Italy; the Dipartimento di Biologia Evolutiva e Funzionale, Università degli Studi di Parma, Parma, Italy; and the Dipartimento di Scienze e Tecnologie Biomediche, Università degli Studi di Udine, Udine, Italy. Department of Translational Research, Experimental Oncology 2 Division, CRO Aviano, National Cancer Institute, Aviano, PN 33081, Italy 1Division of Experimental Oncology 2 and; 4Dipartimento di Scienze e Tecnologie Biomediche and; 5MATI Center of Excellence, University of Udine, Udine, Italy Divisione di Oncologia Sperimentale 2, Centro di Riferimento Oncologico-IRCCS, Aviano 33081, Italy; Dipartimento di Scienze e Tecnologie Biomediche and MATI Excellence Center, Università di Udine, Udine 35100, Italy 3 Divisione di Oncologia Sperimentale 2, Centro di Riferimento Oncologico, 33081 Aviano, Italy; Universitá di Udine 4 Dipartimento di Scienze e Tecnologie Biomediche , , Udine, Italy Department of Molecular Oncology and Translational Research, Experimental Division 2, National Cancer Institute CRO-IRCCS, Aviano, Italy; Department of Sciences and Biomedical Technology, University of Udine, Udine, Italy; MATI Center of Excellence, University of Udine, Udine, Italy Division of Experimental Oncology 2, CRO, National Cancer Institute, Aviano, Italy; Department of Scienze Biologiche e Mediche, MATI Center of Excellence, University of Udine, Udine, Italy Division for Experimental Oncology 2The National Cancer Institute CRO‐IRCCS Aviano PN 33081 Italy; MATI Centre of ExcellenceUniversity of Udine Piazzale Kolbe Udine 35100 Italy Division of Experimental Oncology 2, CRO, National Cancer Institute, Aviano, Italy; Department of Biomedical Sciences and Technologies, MATI Center of Excellence, University of Udine, Udine, Italy Division of Experimental Oncology 2, Centro di Riferimento Oncologico, National Cancer Institute, Aviano 33081, Italy; Dipartimento di Scienze e Tecnologie Biomediche and MATI Center of Excellence, University of Udine, 33100 Udine, Italy 5Experimental Oncology 2, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano, Italy. University of Udine, Udine, and CRO-IRCCS National Cancer Institute, I-33081 Aviano, Italy. Molecular Oncology Unit, Centro di Riferimento Oncologico, IRCCS-National Cancer Institute, Aviano, PN, Italy (Laboratorio di Oncologia Sperimentale dell'Istituto di Anatomia Patologica dell'Università, Padova) 1Experimental Oncology 2, CRO Aviano National Cancer Institute, Aviano, Italy.; 2Department of Medical and Biological Science Technology and MATI (Microgravity Ageing Training Immobility) Excellence Center, University of Udine, Udine, Italy. Division of Experimental Oncology 2, Department of Translational Research, CRO-IRCCS, Aviano, Pordenone, Italy Divisione di Oncologia Sperimentale 2, CRO-IRCCS, 33081 Aviano, Italy; Dipartimento di Scienze e Tecnologie Biomediche, University of Udine, Udine, Italy; MATI Center of Excellence, University of Udine, 35100 Udine, Italy Experimental Oncology 2, Aviano National Cancer Institute (CRO), Via Franco Gallini 2, 33081 Aviano, Italy; Department of Medical and Biological Science Technology, Microgravity Ageing Training Immobility Excellence Center (MATI), Piazzale M. Kolbe, 33100 Udine, Italy *Division of Experimental Oncology 2,; Dipartimento di Scienze e Tecnologie Biomediche and; MATI Center of Excellence, University of Udine, 33100 Udine, Italy The National Cancer Institute 1 , CRO, IRCSS, Division for Experimental Oncology 2, Via Pedemontana Occidentale 12, Aviano (PN) 33081 Italy; University of Udine 2 Department of Medical Science and Technology , , 35100 UDINE, Italy Department of Translational Research Experimental Oncology Division 2 CRO Aviano Italy; MATI Centre of Excellence University of Udine Italy Unit of Molecular Oncology Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Aviano Italy 1Divisione di Oncologia Sperimentale 2, CRO-IRCCS, National Cancer Institute, 33081 Aviano, Italy; 4Dipartimento di Scienze e Tecnologie Biomediche, University of Udine, 33100 Udine, Italy; 5MATI Center of Excellence, University of Udine, 33100 Udine, Italy Divisione di Oncologia Sperimentale, CRO-IRCCS, 33081 Aviano, Italy Laboratorio di Oncologia Sperimentale, Istituto di Anatomia Patologica dell'Università, Padova Experimental Oncology 2, Department of Translational Research, CRO-IRCCS, National Cancer Institute, 33081, Aviano, Italy Department of Translational Research, Experimental Oncology Division 2, CRO, Aviano, Italy From the Laboratory of Experimental Oncology, Institute of Pathological Anatomy, University of Padova, and the Viral Leukemia and Lymphoma Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014 1Experimental Oncology 2, Centro di Riferimento Oncologico, IRCCS, National Cancer Institute, Experimental Oncology 2, Via F. Gallini 2, Aviano (PN), 33081, Italy; University of Udine, Department of Medical & Biological Science Technology, Piazzale Kolbe 3, Udine, 33100, Italy; University of Udine, MATI (Microgravity, Ageing, Training, Immobility) Centre of Excellence, Italy Division for Experimental Oncology 2The National Cancer Institute, IRCCS‐CROVia Pedemontana Occidentale 1233081AvianoPNItaly; Department of Technical and Biomedical Sciences & Microgravity, Aging, Training and Immobility Centre of ExcellenceUniversity of UdinePiazzale Kolbe33100UdineUDItaly Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Italy |
Incoming Links
Total number of triples: 201.